Quince Therapeutics files 8-K on name and symbol change
Quince Therapeutics said it issued a press release on a name change amendment and a symbol change, according to its Form 8-K filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Quince Therapeutics files 8-K on director changes
Quince Therapeutics said several directors resigned from its board and named four new directors effective Oct. 8, 2026. The filing also disclosed compensation terms for Keith R. Fandrick.